Product Liability Archive » October, 2013

Product Liability - October, 2013

347 articles

• Exxon Can't Dodge Class Actions Over Ark. Pipeline Rupture
• Tobacco Cos. Lose Bid To Oust Counsel In Canadian Suit
• Ex-Donziger Ally Says He Was Told Of Fraud In $19B Suit
• Clinical Trial Deaths Lead Ariad To Halt Iclusig Sales
• House Dems Rip USTR Tobacco Proposal In Pacific Trade Pact
• Helmerich Unit Agrees To Pay $6M To End Rig-Testing Probe
• Alstom Forces Insurer To NY Arbitration In $33M Building Row
• J&J Unit Slapped With $4M Verdict Over Topamax Birth Defects
• 4 Settlement Lessons From NFL Concussion Deal
• Risky Business Of FDA Mobile Medical Apps
• FAA To Allow Electronic Device Use During Takeoff, Landing
• AstraZeneca Discloses US Investigation Into Heart Drug Trial
• FDA Launches Two-Prong Attack On Drug Shortages
• Apple Shuts Down Faulty MacBook Class Action
• Order To Scrub Website Violated Atty's Rights: Calif. Court
• Evidence Doesn't Back Anti-Concussion Claims, IOM Says
• Canadian High Court Won't Adopt US-Style Class Cert. Test
• Barnes & Noble Ordered To Face NY Hot-Tea Injury Suit
• New York City Raises Tobacco Sales Age Limit
• 6th Circ. Won't Hear Appeal Of Darvocet Suit Remand
• Halloween Scares Haunt Dreams, Not Defendants
• Worker Injured In Deadly Oil Rig Blast Sues Black Elk
• Anheuser-Busch Sued Over 'Imported' Beer Brewed In USA
• Butler Snow Adds Baker Botts Product Liability Expert In NY
• FTC Says Marketer Exaggerated Weight Loss Claims
• Legal Demand Is Up — How Are Law Departments Managing?
• No Secrets About Pesticides In EU And Possibly Abroad
• Ferry Service Pays $1M To Settle Claims Over NYC Crash
• LG Can't Get Refrigerator Defect Suit Cut Down
• FDA Chides Sunovion Over Misstating Brovana Risks, Benefits
• Okla. Supreme Court Gives Harsh Take On Abortion Drug Law
• Donziger Wants Key Chevron Witness Testimony Booted
• Schiff Hardin Nabs 2 Goodwin Procter Product Liability Attys
• CPSC Officials Say Cuts Imperil Import Oversight Program
• 11th Circ. Sends Carnival Worker Suit To Foreign Arbitration
• Expanded 'Sophisticated User' Defense Nixed In Asbestos Suit
• Allergan Can't Beat Widower's Botox Poisoning Suit
• To Dodge Mensing, Plaintiffs May Target Foreign Drugmakers
• UK To Ban Hospitals' Use Of Many Metal Hip Implants
• Alleged Bin Laden Associate Sanctioned In 9/11 MDL
• Bill Risks Confusion To Curb FDA's Already-Lax App Oversight
• Tobacco Display Ban Up In Smoke As NYC Anti-Cig Bills Pass
• 4th Circ. Hears Black Lung Fraud Case Against Jackson Kelly
• Revived Cert. Bid In Volvo Engine Defect Suit Blocked
• 7th Circ. Gives Mead A 2nd Chance At False Ad Coverage
• Ex-Chemical Co. President Gets 1 Year In Worker Death Case
• Taiwan Steps Up US Beef Inspections After Scare
• Wis. Court Ups AIG Defense Costs In Coca-Cola Asbestos Row
• Baby Carrier Maker Hit With Suit Over Misleading Marketing
• Asbestos Plaintiffs Assail Venue Transfer In Pa. Mass Tort
• Takeaways From McPhee V. DePuy's Preemption Pronouncement
• Walgreens Sued Over Cartilage Rebuilding Supplement
• Honda Beats Suit Over Defective Gold Wing Motorcycles
• Calif. Appeals Court Reverses GM Defect Judgment
• BP Spill Settlement Administrator Sets New Claims Criteria
• Fracking Secrets Still Vulnerable After Gag Order Ruling
• 9th Circ. Partly Blocks Chevron Email Info Bid In $19B Suit
• Nestle Beats False Ad Suit Over 'All Natural' Pasta
• Draeger Escapes Suit Over Faulty Breath-Alcohol Testers
• FDA Proposes New Animal Food Safety Regs
• Wal-Mart Faults Science In Supplement False Ad Suit
• China Beefs Up Data Privacy, Consumer Protection Penalties
• Canadian Court Won't Shrink Paxil Birth Defect Class
• Fed. Circ. Curbs Future Earnings Recovery In Vaccine Deaths
• Schulte Scores $21M Payday For Quigley Bankruptcy Work
• Coming Soon: Paradigm Shift In Genetic Resources Regs
• Whirlpool Can't Freeze Out Energy Star Warranty Class Action
• Star Chevron Witness's Credibility Under Fire In $19B Suit
• NHTSA Won't Probe Tesla Car's Battery Fire
• Dow Seeks En Banc Review Of Cancer Cluster Suit
• Seaman Wants BP On Hook For $2.7M Deepwater Deal
• Hip Implant Recall Costs Could Top $1B, Stryker Says
• Fla. Justices Reinstate Law Firm's $1.2M Chair Injury Judgment
• NYC Can't Sue Architects Over Hospital Damage
• Novo Nordisk Recalls Insulin Pens All Over Europe
• Frito-Lay Dodges Some Claims In Nutrition Label Class Action
• FDA Proposes Safety Rules For Animal Food
• Lumina Diet Supplement Class Action Stays In Fed. Court
• Insurers Balk At Contractors' LA Live Tile Defect Claims
• Perdue Accused Of Lying About 'Humane' Chicken Treatment
• Jury Hits Toyota With $3M Verdict In Fatal Crash Suit
• Ky. High Court Nixes Fen-Phen Malpractice Suit Against Firms
• Estee Lauder Unit Wins $3.6M In IP, False Ad Row
• FDA Pushes Tougher Controls On Hydrocodone Painkillers
• Nature's Products Hit With $3.3M Verdict Over Prolab Recall
• Nord Says CPSC May Have To Sue To Force Recalls
• Donziger Takes Aim At Key Chevron Witness In $19B Trial
• OSHA Issues Tougher Chemical Guidelines For Employers
• 6th Circ. Revives Wrongful Death Suit Against HHS
• The Inherent Risks In Purchasing Assets Of A Predecessor
• CPSC Chief To Join Nelson Mullins' Products Team In Dec.
• GSK Can't Sink Avandia Prescription Coverage RICO Suits
• USDA Defends New Meat Labeling Regulations In DC Circ.
• 5 Calif. Laws Experts Say Could Use A Facelift
• Troutman Sanders Nets Ex-McCarter Product Liability Atty
• 49ers Shooting Suit Sacked Over Team Citizenship
• FDA Urged To Get Specific In Facility Inspection Reports
• No End In Sight For Engle Suits, Even With Liggett Deal
• Lorillard Pays $79M To Settle Mass. Smoker Case
• Bipartisan Bill Would Curb FDA's Medical Apps Oversight
• Ex-Judge Testifies To Taking Bribes In $19B Chevron Trial
• Texas Doctors Lose Bid To Curb Coal Plant Pollution
• Marlboro Lights Marketing Suit Will Get Class Cert.
• Defeating Economic Loss Claims In Pharma Class Actions
• Liggett Reaches $110M Deal To End Most Engle Smoker Suits
• Judge Trims Doc's $2.2M Indemnity Suit Against Device Maker
• RICO A Tempting Route For Companies Facing Tort Trickery
• Insulation Co. Sues 15 Insurers For Asbestos Coverage
• BP Gulf Spill Settlement Payment Freeze Extended
• EU Lawmakers Back Medical Device Reforms
• Pa. House OKs Bill To Let Docs Apologize Without Liability
• GAO Urges Timeline To Battle FDA Lag On Tobacco Approvals
• Pa. Nuke Facilities Operators Sued Over Hazardous Releases
• Weight Loss Guru Jailed For Contempt In FTC Feud
• Be Careful With Your Employees' Online Reviews
• Insurer Fights For 6th Circ. To Rehear Indians Fan Death Suit
• 8th Circ. Affirms Sherwin-Williams Win In Loss Doctrine Case
• Bombardier Says Sub Caused Delays In Airport Train Project
• Calif. Atty Says Monster Marketing Feud Hinders State Suit
• With Gov't Shutdown Over, Stay Lifted In Exxon Spill Suit
• Feds Say Exxon Can't Sue Gov't Over Contamination Cleanup
• Shutdown Affected Food Safety Deadline, FDA Tells 9th Circ.
• FDA Cannot Regulate Stem Cell Treatments, DC Circ. Hears
• Ford Seeks To Ax Firm's Suit Over Taurus Navigation System
• OSHA Rule May Not Be Reviewable In Court, DC Circ. Says
• Shipyard Ducks $78M FCA Suit Over Flawed Coast Guard Hulls
• FDA Largely Rejects Prometheus Petition On Drug Risks
• NCAA To Mediate With 2nd Group Of Concussion Plaintiffs
• High Court Won't Hear Novo Foreign Liability Case
• $2M Verdict Stands In Bard Vaginal Mesh Bellwether
• High Court Seeks SG Input In Terror Aid Sanctions Case
• How To Prepare Witnesses To Make (Not Break) Your Case
• A Lesson On Liability Risks For Device And Pharma Cos.
• BP's Fines For Deepwater Horizon Spill To Be Tallied
• Settlement Class Says Deepwater Deal Should Be Affirmed
• Jury Awards Engle Plaintiff $11M Against Philip Morris
• Fla. Court Asks For Clarity On Engle Punitive Damages Issue
• Bulky Novartis Eyedrop Boxes Mislead Buyers, Calif. DAs Say
• Travelers Sues Parts Maker To Duck Asbestos Suit Coverage
• Specialty Food Co. Accused Of Selling Bogus 'Raw' Juice
• Lifeway Accused Of Masking Smoothies' Sugar Content
• Texas High Court Takes Fight Of Pollution 'Stigma' Damages
• FDA Rebuffs Alimera Diabetes Eye Treatment Over Concerns
• Bard Pushes For Costs In Dropped Vaginal Mesh Bellwether
• Colo. Farm Owners Blame Auditor For Outbreak In Lawsuit
• Medical Monitoring Claims Cut From Faulty Insulation Suit
• Latest Developments And Trends In Fracking
• Insurers' Suit Over $146M Train Crash Settlement Survives
• Shutdown Threatens To Keep Product Safety Rules On Shelf
• Weight Watchers Trounces Ice Cream Calories Class Action
• Donziger Used Bogus Report To Batter Chevron, Witness Says
• Wash. Targets Food Makers For Anti-GMO Labeling Campaign
• J&J Can't Stop Baby Sleep Aid False Ad Action
• SCE Seeks $4B From Mitsubishi Over Nuke Plant Shutdown
• FCA's Scope Widens As 8th Circ. Embraces Little-Used Theory
• Monsanto Genetic Engineering Battle Consolidated In Kan.
• Citgo Asks High Court To Nix $180M Oil Spill Suit
• Attys Group Asks High Court To Review Class Cert Precedent
• EU Committee Drafts Stricter Product Safety Rules
• Pa. Justices Reject Wyeth's Appeal Of $11M Prempro Suit
• Boston Scientific To Pay $30M In Defibrillator FCA Suit
• Top NY Court Will Hear Bloomberg's Large-Soda Ban Appeal
• Misbranded Drugs — A Danger To Physicians And Patients
• Jindal Names New Members To Board That Sued Energy Cos.
• Railway Exec Not Covered For Quebec Crash, State Farm Says
• NY High Court Expands Property Owners' Vandalism Coverage
• Toyota Ducks Liability For Lexus Dealer's Acceleration Case
• Former Hostess Co. Settles Bad Bread Suit With Utah Bakery
• Bayer Escapes 60 Suits In Mass Tort Over Yaz, Yasmin
• Statewide Class Cert. Stands In Volvo Sunroof Suit
• Donziger Faces Former Ally In $19B Chevron RICO Trial
• Symantec Customer Says Data Breach Suit Must Go On
• NJ High Court's Major Shift In Favor Of Policyholders
• BMW's Auto Start Stop Is Life-Threatening, Suit Says
• 2 Brothers To Enter Plea Deals In Tainted Cantaloupes Case
• Clif Bar Can't Halt Lead Warning Case
• 2nd Circ. Won't Rethink Exxon's $105M Pollution Verdict
• Zimmer, Marketer Push For Retrial In $28M Knee Injury Row
• FDA Advises Against Antifungal Drug's Use In Studies
• FELA Firm Can't Dodge Trial In Malpractice Suit
• Philips AirFloss Buyers Shafted In False Ad Deal, Group Says
• Braun Yanks Antibiotic Over Life-Threatening Particles
• Nestle Says False Ad Suit Doesn't Define 'All Natural'
• 38 Drugmakers Tricked State Medicaid Agency, La. Says
• Chevron, Donziger Trade Blows As $19B RICO Trial Begins
• Supplements Contain Meth-Like Substance, Study Says
• Australian Regulators Target Caffeine Combo Stimulants
• FDA Lays Out Limits For Drug Impurities
• Frito-Lay Denies Misleading Consumers About GMOs
• Supreme Court Won't Mull Hospira's Duty To Supply Drug
• Ex-Halliburton Worker Cops To Ditching Deepwater Evidence
• Cozen O'Connor Adds 5 Partners To NY Litigation Group
• 8th Circ. Revives DOD Fraud Claims In Bayer FCA Suit
• BP Tells 5th Circ. Deepwater Deal Needs Redo On Remand
• What China's Lemon Law Will Mean For Manufacturers
• Calif. Governor Vetoes Biosimilars Substitution Bill
• Marriott Sells Inferior Meat As 'Kobe Beef,' Suit Says
• Respondeat Superior Can Continue After Closing Time
• Maine Law Muddles Liability In Drug Injury Suits
• Cert. Granted In Defective Frigidaire Washing Machine Row
• BP Loses Bid To Send Deepwater Securities Suit Abroad
• Judge Won't Toss Obstruction Case Against Ex-BP Engineer
• $9M Shaved From Novartis Jaw Injury Award By NY Judge
• Medtronic Surgery Advice Suit Not Preempted: Ind. Court
• The Best Question To Ask Your Potential Outside Counsel
• Bard Berated For Fee Demand In Dropped Vaginal Mesh Suit
• FDA Eyes Ariad Leukemia Drug After Blood Clot Reports
• Smoking Ban Exceeded State Parks' Authority, Judge Says
• Gamers Sue Over 'Grand Theft Auto V' Online Delays
• EU Panel Says Contraceptive Benefits Outweigh Clot Risks
• Energy Pro Kicks Off 2nd Tour Of Duty At Hicks Thomas
• O'Quinn Sues For Coverage Of $46.5M Overbilling Settlement
• How To Fight A Punitive Damage Claim In Light Of Maddox
• Adams & Reese Adds Music Industry Vet In Nashville
• Jury Finds Toyota Not Liable In Bellwether Crash Case
• Ecuador Asks To Join $19B RICO Suit In Pretrial Jockeying
• Miami Dade College Sues Builders Over Fatal Garage Collapse
• EU Lawmakers OK Cadmium, Mercury Bans In Batteries
• Pa. Justices Won't Review 'Any Breath' Asbestos Case
• Shutdown Harms CDC's Outbreak Tracking, Dems Say
• AIG Says Insureds Can't Sue It For Targeting Wrongdoers
• Jaguar Gets Range Rover Suspension Defect Suit Pared
• OSHA Knocks Texas Fertilizer Plant For Failings Before Blast
• Cancer Cluster Suit Against Dow Unit Revived In Pa.
• BP Beats Damages In $10B Toxic Emission Test Case
• BP Expert Testifies US Spill Estimate Disregards Science
• Natrol Faces False Ad Suit Over Joint-Health Supplement
• Juror Stays On Toyota Crash Trial After Intoxication Claim
• High Court No Help To Companies Left Off Arbitration Pacts
• Donziger Finances Under Scrutiny As Chevron Trial Nears
• Fla. Medical Institute Wants Opposing Counsel Disqualified
• USDA Threatens To Close Poultry Facilities Linked To Outbreak
• US Says BP Analysis Supports High Deepwater Spill Estimate
• Monsanto Wins Arbitration Bid In Defective Cottonseed Row
• FTC's Increasingly Aggressive Assertion Of Authority
• EU Trade Chief Blasts Russian Ban On Lithuanian Imports
• Chemical Group Counters Rep. On Support For Law Reform
• Maine Drug Importation Law Takes Effect Amid Controversy
• Retailer Group Opposes FDA Restrictions On Menthol Cigs
• Fla. Appeals Court Won't Revive Colombian Native's Engle Suit
• FAA Recalls 800 Furloughed Aircraft Safety Inspectors
• Lion Wants $80M In Exxon Pipeline Breach Losses Covered
• Toyota Misled Buyers Of Pre-Crash Safety System, Suit Says
• Pfizer Hit With Suit Claiming Lipitor Caused Diabetes
• Gov't Shutdown: A Setback For FDA's Momentum
• 3rd Circ. Says Gov't Seizure Of Lab's Property Lawful
• Calif. Gov. Signs Compounding Pharmacy Oversight Bill
• USDA Links Salmonella Outbreak To Calif. Poultry Company
• FDA Links Deadly Hepatitis Cluster To Popular Supplement
• GNC Seeks Toss Of Muscle Supplement False Ad Row
• J&J Faces Class Action Over 'Natural' Aveeno Sunscreen
• Ogletree Abbott Says FindLaw Botched Web Redesign
• Bard Wants Atty Fees For Dropped Mesh Bellwether
• FDA Chides Device Maker Nidek Over Quality Controls
• Toyota Nixes Some Expert Testimony From Acceleration Trial
• Scientists Back US Estimate For Deepwater Horizon Spill
• Stryker OK'd To File New Knee Coverage Claims Against TIG
• EU Lawmakers Loosen E-Cig Regs In Anti-Tobacco Plan
• Let's Really Consider The Idea Of A 2-Year Law Degree
• NJ Water Commission Can't Revive Suit Over Plant Failure
• Jury Urged To Slam BP As $10B Toxic Emissions Trial Ends
• Fla. Court Nixes Verizon's Coverage For Violent-Contractor Suit
• Whirlpool, Sears Ask Justices To Rethink Class Cert. Rulings
• 'Cane Juice' Label May Be Illegal Under Calif. Law, Judge Says
• High Court Won't Mull Punitives In Drug Labeling Suits
• Calif. Gov. OKs Bill To Curb Chemical Warning Suits
• EPA To Reveal Fuel Efficiency Audit Results
• Big Tobacco's Engle Appeal Falls Flat In High Court
• Justices Won't Hear Design Defect Suit Over Generic Reglan
• J&J Escapes Damages In Suit Linking Body Powder To Cancer
• EU, Canada Want In On WTO Row Over Australian Tobacco Law
• Watchdog Shuts Down Supragenix, Wellnx Supplement Claims
• Judge Unveils Records In FOIA Suit Targeting Pfizer, Purdue
• High Court Wants SG's Views In Medtronic Pain Pump Row
• Insurer Can't Use Pollution Exclusion To Exit Drywall Suit
• Justices Pass On Toyota's Brake Defect Arbitration Appeal
• Pa. Superior Court Won't Rehear Reglan Preemption Appeal
• High Court Won't Review Feraheme Investor Class Action
• Miss. Judge Fined Over Misconduct In $322M Asbestos Case
• BP Attacks US Oil Spill Estimate As Unreliable
• Berkshire Insurer Pays $22M To Settle Ford Coverage Row
• Calif. Class Consumer Fraud Cases Continue To Survive
• Donziger Denied Jury Trial In $19B Chevron Fight
• Class Cert. Denied In Dow, Union Carbide Contaminant Suit
• Donziger Defends Right To Jury In $19B Chevron RICO Trial
• Calif. Ruling Offers New Tool To Fight Food Labeling Claims
• Jury Hits Continental Tire With $11M Verdict Over Blowout
• FDA Quality Grades Could Leave Drugmakers Smarting
• NJ Judge Trims Claims In Class Suit Over Train Derailment
• The Best Cyberdefense Is A Good Offense
• Lyondell, ARCO, Fresno Dismiss Claims In MTBE MDL
• Judge Delays Wind-Down In MDL Over Merck's Fosamax
• House Bill Would End Shutdown For FDA
• BP Secures Freeze Of Some Gulf Spill Settlement Payments
• Crest False Ad Settlement Gets NJ Judge's Final Nod
• Attune Faces Suit For Listing 'Cane Juice' As Ingredient
• Doctrine Of Consent Will Blossom Again In Calif.
• Judge Trims Deepwater Securities Suit Against BP, Execs
• Mass. House OKs Bill To Reform Compounding Regs
• NH Appeals Set-Aside Of Record $236M Exxon MTBE Verdict
• Home Siding Co. Pays $104M To Settle MDL Over Defects
• Flintkote Keeps Asbestos Coverage Disputes In Arbitration
• J&J Settles Hip Implant Case Set For Trial In Calif.
• Gov't Shutdown Stalls FTC's Bid To Jail Infomercial Star
• Riddell, NCAA Face New Football Concussion Class Action
• Considerations Before Counseling During Deposition
• Masimo Escapes FCA Row Over Allegedly Shoddy Devices
• Hospira Woes Continue As Glass Contamination Spurs Recall
• BP Stresses Safety, Caution At Close Of Oil Spill Defense
• Blue Diamond Can't Shake Almond Milk Labeling Class Action
• Contractor, AIG Demand $45M Plane Crash Coverage From US
• Demolition Legislation Introduced In Philly City Council
• Drone Pilots Immune From FAA Fines, Judge Told
• 5th Circ. Grants BP Reconsideration Of Deepwater Payouts
• Biosimilars Guidance, Drugmaker Grades Coming, FDA Says
• Ecuadorean Judge To Testify In $19B Chevron RICO Row
• Local NJ Businesses Sue Conrail Over Train Derailment
• ConAgra Asks 7th Circ. To Nix $180M Award To Blast Victims
• Merck Opposes Delay In Wind-Down Of Fosamax MDL
• Chevron Zeroes In On Endgame In $19B Ecuador Saga
• Power Transmission Co. Not Liable For Injury, Pa. Court Says
• 5 Tips For Leveraging Experts To Optimize Client Value
• Fla.'s Recent Fight In The Zometa Evidentiary Battle
• CPSC Approves Cradle Safety Standard Over Objection
• 3rd Circ. Ruling Imperils Consumer Class Actions, Group Says
• FDA Lays Out Rules For Early Study Of Higher-Risk Devices
• BP Officials Say Gulf Spill Control Efforts Were Justified
• New Bill Would Perpetuate FDA-State Compounding Confusion
• Merck's $688M Vytorin Settlement Wins Judge's Nod
• 2nd Apple Button-Defect Class Action On Verge Of Transfer
• Nestle, California Pizza Kitchen Sink Trans Fat Class Action
• Dealership Allowed To Sue Firm Over Pursuit Of Asbestos Suit
• FDA Withdrawing Approval For Some Toxic Animal Feed Drugs
• Symantec Again Aims To Get Data Breach Suit Junked
• Ohio Drillers Can't Dodge EPA Chemical Reporting Regs
• Pa. Utility Defends Settlement Tied To Power Line Death
• FDA Warns Of Potential Safety Issues In Nephron Asthma Drug
• Judge Pares Down Arm & Hammer Deodorant False-Ad Claims
• Novartis Takes Aim At Cross-Appeal In Zometa Suit
• Don't Conflate Shutdown And Debt Ceiling Challenges
• BP Blamed For Extending Gulf Oil Spill By Bungling Response
• Safer Consumer Products Act May Be Regulatory Overkill
• Unilever Can't Escape Suave Hair Loss Class Action
• Catheter Kickback FCA Suit Brings No New Proof, Bard Says
• US Government Shuts Down As Funding Fight Goes Nowhere
• BigLaw Braces For Revenue Hit In Federal Shutdown
• User Fees Won't Save FDA Approvals From Shutdown's Snare